Evidence map›Paper›PMID 41219921›Full record

ArticleBMC psychiatry2025

Anxiety disorder is a common psychopathological comorbidity in patients with SHANK pathogenic variants: description of five new cases.

Carmen Manso-Bazus, Nino Spataro, Laura Plans, Meritxell Tomàs, Mercè Casadesús, Montserrat Pamias, Anna Ruiz

Abstract read
In one paragraph

Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carmen Manso-BazusCenter for Genomic Medicine, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, 08208, Spain.
Nino SpataroCenter for Genomic Medicine, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, 08208, Spain.
Laura PlansDivisió de Salut Mental, Althaia, Xarxa Assistencial Universitària de Manresa, Manresa, 08243, Spain.
Meritxell TomàsDivisió de Salut Mental, Althaia, Xarxa Assistencial Universitària de Manresa, Manresa, 08243, Spain.
Mercè CasadesúsDivisió de Salut Mental, Althaia, Xarxa Assistencial Universitària de Manresa, Manresa, 08243, Spain.
Montserrat PamiasDepartment of Mental Health . Sant Joan de Déu Terres de Lleida, Lleida, Spain.
Anna RuizCenter for Genomic Medicine, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, 08208, Spain. aruizn@tauli.cat.

Funding

Institut d'Investigació i innovació Parc Taulí I3PT CIR2020/021Instituto de Salud Carlos III-FEDER PI19/01902
6 · The paper itself

Abstract

backgroundPathogenic variants in the SHANK family genes have been linked to autism spectrum disorder, as well as to other neuropsychiatric and neurodevelopmental disorders. We aim to characterise the neurodevelopmental, neuropsychiatric and dysmorphic features of five additional patients with SHANK1 and SHANK2 and SHANK3 pathogenic variants to highlight a prevalent neuropsychiatric phenotype common to SHANK family members.

methodsWhole exome sequencing was performed in 115 patients (aged 6-18 years) with mild intellectual disability/borderline intellectual functioning and a psychiatric comorbidity. Neurodevelopmental, clinical, psychopathological and dysmorphological features of patients with pathogenic variants in SHANK genes were collected.

resultsIntragenic pathogenic variants in SHANK1, SHANK2, and SHANK3 were identified in five patients. All patients presented significant language and motor delay and autism spectrum disorder as the most prevalent psychiatric comorbidity. Generalised anxiety disorder was present in four out of five patients, while one patient presented a non-specific anxiety disorder.

conclusionsThis study identifies five new patients with pathogenic variants in the SHANK genes that present generalised anxiety disorder as a common psychopathological comorbidity. Identification of the underlying genetic cause in children and adolescents with mild or borderline intellectual disability may improve their clinical management, allowing a personalized approach, and providing precise genetic counselling to the family.

Indexed as

Anxiety DisordersIntellectual DisabilityNerve Tissue ProteinsAdolescentAutism Spectrum DisorderChildComorbidityExome SequencingFemaleHumansMaleNerve Tissue ProteinsSHANK2 protein, humanSHANK3 protein, humanGeneralised anxiety disorderNeurodevelopment disorderSHANK1SHANK2SHANK3

Identifiers

PMID41219921
PMCPMC12606811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.